Showing results (151-160 of 270) with videos related to
Sort By:
Pageof 27
Medicine and Science in Sports and Exercise|May 5, 2005
Modulation of immune response by the acute and chronic exposure to high altitudeMonica Facco, Chiara Zilli, Marta Siviero, et al.The European Respiratory Journal|August 29, 2024
Pulmonary hypertension associated with lung diseasesOksana A Shlobin, Yochai Adir, Joan A Barbera, et al.ERJ Open Research|November 26, 2024
Surfactant-derived protein type B: a new biomarker linked to respiratory failure and lung damage in mild to moderate SARS-CoV-2 pneumoniaMassimo Mapelli, Elisabetta Salvioni, Irene Mattavelli, et al.European Heart Journal|August 1, 2021
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patientsGiulio Francesco Romiti, Bernadette Corica, Eugenia Pipitone, et al.International Journal of Clinical Practice|September 12, 2021
COVID-Q: Validation of the first COVID-19 questionnaire based on patient-rated symptom gravityGiacomo Spinato, Cristoforo Fabbris, Federica Conte, et al.Diabetes Care|November 1, 2012
Diabetes impairs stem cell and proangiogenic cell mobilization in humansGian Paolo Fadini, Mattia Albiero, Saula Vigili de Kreutzenberg, et al.Journal of Clinical Medicine|August 29, 2024
Mortality during the SARS-CoV-2 Pandemic: A Comparative Analysis between Lombardy in Italy and IsraelRonza Najjar-Debbiny, Alessandro Nobili, Pier Mannuccio Mannucci, et al.Diagnostics (Basel, Switzerland)|April 23, 2022
The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell HistiocytosisAlexander Poellinger, Sabina Berezowska, Jeffrey Leon Myers, et al.Expert Review of Anticancer Therapy|June 21, 2025
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectivesGiuseppe Pelosi, Maria Gemelli, Fabrizio Bianchi, et al.The Lancet. Respiratory Medicine|November 3, 2024
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm studySergio Harari, Davide Elia, Antonella Caminati, et al.Pageof 27